Copyright
©The Author(s) 2000.
World J Gastroenterol. Oct 15, 2000; 6(5): 747-749
Published online Oct 15, 2000. doi: 10.3748/wjg.v6.i5.747
Published online Oct 15, 2000. doi: 10.3748/wjg.v6.i5.747
Group | 48 h | 72 h | ||
MTT value (x-± s) | Inhibition rate (%) | MTT value (x-± s) | Inhibition rate (%) | |
Control | 0.445 ± 0.016 | 0.337 ± 0.003 | ||
Liposome-RC15 | 0.389 ± 0.015 | 12.6 | 0.091 ± 0.008 | 12.2 |
Liposome-AEGFR | 0.078 ± 0.022 | 82.5 | 0.079 ± 0.005 | 76.6 |
Group | G0/G2 (%) | S (%) | G2 + M (%) | PI |
Control | 21.6 | 59.9 | 18.5 | 0.784 |
Liposome-RC15 | 29.5 | 54.9 | 15.6 | 0.705 |
Liposome-AEGFR | 57.1 | 32.5 | 10.1 | 0.329 |
Group | Diameter of tumor (cm) | Rate of tumorigenicity (%) |
Control | 1.00 ± 0.08 | 100 (10/10) |
Liposome-RC15 | 0.95 ± 0.07 | 100 (10/10) |
Liposome-AEGFR | 0.80 | 20 (2/10) |
- Citation: He Y, Zhou J, Wu JS, Dou KF. Inhibitory effects of EGFR antisense oligodeox-ynucleotide in human colorectal cancer cell line. World J Gastroenterol 2000; 6(5): 747-749
- URL: https://www.wjgnet.com/1007-9327/full/v6/i5/747.htm
- DOI: https://dx.doi.org/10.3748/wjg.v6.i5.747